IL1R1 and neoplasm: These data show that inhibition of IL-1R signalling with anakinra significantly reduces subcutaneous growth of both ER+ve and ER-ve tumours and analysis of MDA-MB-231-IV derived tumours support that this is mediated by altering the tumour microenvironment, increasing tumour cell necrosis and reducing proliferation and angiogenesis.